Alphabet (GOOGL) slips after hours despite Street-beating Q2 >>> READ MORE

5 Medical Devices Stocks to Sell Now

OFIX, ABMD, STJ, ALGN, XRAY slump in weekly rankings


This week, the overall grades of five Medical Devices stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

This week, Orthofix (NASDAQ:OFIX) falls to a D (“sell”), worse than last week’s grade of C (“hold”). Orthofix International N. V. is a global medical device company offering a line of surgical and non-surgical products mainly in the spine, orthopedics, sports medicine and vascular market sectors. For Portfolio Grader’s specific subcategory of Earnings Momentum, OFIX also gets an F. For a full analysis of OFIX stock, visit Portfolio Grader.

This week, Abiomed (NASDAQ:ABMD) drops from C to a D rating. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. As of Jan. 14, 2013, 21.6% of outstanding Abiomed shares were held short. The stock has a trailing PE Ratio of 35.00. To get an in-depth look at ABMD, get Portfolio Grader’s complete analysis of ABMD stock.

St. Jude Medical (NYSE:STJ) earns a D this week, moving down from last week’s grade of C. St. Jude Medical makes and distributes cardiovascular medical devices. For more information, get Portfolio Grader’s complete analysis of STJ stock.

Slipping from C to a D rating, Align Technology (NASDAQ:ALGN) takes a hit this week. Align Technology designs, manufactures, and markets the Invisalign system, which is a proprietary method for treating aligning teeth. The stock also gets an F in Earnings Growth. As of Jan. 14, 2013, 11.2% of outstanding Align Technology shares were held short. The trailing PE Ratio for the stock is 30.40. For a full analysis of ALGN stock, visit Portfolio Grader.

Dentsply International (NASDAQ:XRAY) experiences a ratings drop this week, going from last week’s C to a D. Dentsply International designs and manufactures a range of dental products. The stock’s trailing PE Ratio is 25.30. For more information, get Portfolio Grader’s complete analysis of XRAY stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC